ING Groep »

Jazz Pharmaceuticals shares owned by ING Groep

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by ING Groep from 13F filings

Historical chart of ING Groep investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by ING Groep consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by ING Groep

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.9M 52k 170.00

More positions owned by ING Groep

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Bank of America Corporation (BAC)
Linde SHS (LIN)
Honeywell International (HON)
Select Sector Spdr Tr State Street Ind (XLI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
salesforce (CRM)

View all positions for ING Groep

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
Capital World Investors
Dimensional Fund Advisors
LSV Asset Management
Jpmorgan Chase & Co
State Street Corporation
Franklin Resources
EcoR1 Capital
Hanna Zanoni
Ameriprise Financial
Geode Capital Management
Bank of New York Mellon
GoldenTree Asset Management
Swedbank AB

View all funds holding Jazz Pharmaceuticals